文献速递甲状腺与颈部外科围术期管理与 ERAS

手术治疗降低原发性甲状旁腺功能亢进患者脆性骨折风险

The effect of surgical management in mitigating fragility fracture risk among individuals with primary hyperparathyroidism.
PubMed 文献 · Surgery · 2024-11-16

这项基于人群的队列研究纳入安大略省2007至2016年生化诊断的原发性甲状旁腺功能亢进成人患者,比较接受与未接受甲状旁腺切除术者的骨折发生率。结果显示,手术使12年加权骨折累积发生率从14.04%降至10.17%,每26例手术预防1例骨折,骨折风险降低22%。

要点

  • 甲状旁腺切除术使12年加权骨折累积发生率从14.04%降至10.17%。
  • 每26例甲状旁腺切除术可预防1例骨折(加权风险差3.87%)。
  • 手术使骨折风险降低22%(加权HR 0.78,95%CI 0.64-0.95)。

核心结论

  • 在大型公共资助医疗系统中,甲状旁腺切除术显著降低原发性甲状旁腺功能亢进患者短期和长期脆性骨折风险。

研究设计与样本

  • 基于人群的队列研究,利用行政健康数据库识别2007至2016年安大略省生化诊断原发性甲状旁腺功能亢进的成人(≥18岁)。
  • 纳入标准为钙≥2.6 mmol/L(≥10.42 mg/dL)且同期甲状旁腺激素≥2.2 pmol/L(≥20.75 pg/mL)。
  • 共纳入28,059例患者,平均年龄65岁(标准差14.2岁),75%(n=21,139)为女性。

主要发现

  • 仅12.6%(n=3,523)接受了甲状旁腺切除术。
  • 诊断后12年加权骨折累积发生率:手术组10.17%(n=182),非手术组14.04%(n=2,004)。
  • 甲状旁腺切除术每26例手术预防1例骨折(加权风险差3.87%,95%CI 0.96%-6.62%)。
  • 手术使骨折风险降低22%(加权HR 0.78,95%CI 0.64-0.95)。

临床怎么用

  • 对生化诊断的原发性甲状旁腺功能亢进患者,甲状旁腺切除术可显著降低脆性骨折风险,支持手术治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary hyperparathyroidism predominately affects women who are postmenopausal and causes complications, including fragility fractures. Its treatment is parathyroidectomy, which is associated with low complication and >95% cure rates. Considering fractures are associated with premature death, we aimed to determine whether the surgical management of individuals with biochemical diagnosis of primary hyperparathyroidism was associated with a reduction in fracture risk. METHODS: In this population-based cohort study, we used administrative health databases to identify adults ≥18 year old who were biochemically diagnosed with primary hyperparathyroidism between 2007 and 2016 in Ontario. Patients were included if their calcium was ≥2.6 mmol/L (≥10.42 mg/dL) with a concurrent parathyroid hormone of ≥2.2 pmol/L (≥20.75 pg/mL). We followed patients and compared the incidence of fractures between those with and without parathyroidectomy. To control for potential confounding, we used inverse probability of treatment weighting to estimate the average treatment effect in the treated. Fine-Gray competing risk regression models were used to determine the association between surgery and time to fracture. RESULTS: In a cohort of 28,059 with a biochemical diagnosis of primary hyperparathyroidism, the mean age (standard deviation) was 65 years (14.2 years), and 75% (n = 21,139) were female. Only 12.6% (n = 3,523) underwent parathyroidectomy. Weighted fracture cumulative incidence at 12 years postdiagnosis was 10.17% (n = 182) in surgical patients and 14.04% (n = 2,004) in nonsurgical patients. Parathyroidectomy prevented 1 fracture for every 26 surgeries performed (weighted risk difference, 3.87%, 95% confidence interval, 0.96%-6.62%) and reduced the hazard of fracture by 22% (weighted hazard ratio, 0.78; 95% confidence interval, 0.64-0.95). CONCLUSION: In a large, publicly funded health system, parathyroidectomy significantly reduced the short- and long-term risk of fragility fractures in patients with primary hyperparathyroidism.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Golbon B, Habashi R, Shellenberger J, et al. The effect of surgical management in mitigating fragility fracture risk among individuals with primary hyperparathyroidism. Surgery. 2024. PMID: 39550240. doi:10.1016/j.surg.2024.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。